The report from congressional Democrats found that Trump's pharmaceutical stock holdings grew from a maximum reported value of $1.7 million in 2024 to as much as $56.2 million at the end of 2025.
The report from congressional Democrats found that Trump's pharmaceutical stock holdings grew from a maximum reported value of $1.7 million in 2024 to as much as $56.2 million at the end of 2025.
<iframe src="https://statesidedaily.com/embed/cluster/8d4af2d11f707e9544cb41b8075c3155ffd8ccdc" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Democrats say Trump increased investments in drugmakers that were given Medicare exemptions"></iframe>
